Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-face comparison of Eucerin UltraWHITE+ Spotless vs hydroquinone + arbutin for skin hyperpigmentation
TCTR20190614008Phase 3Completed
- Sponsor
- King Chulalongkorn Memorial Hospital
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of hydroquinone and arbutin in Hyperpigmentation (2 arms), sponsored by King Chulalongkorn Memorial Hospital. Started Mar 2019; status: completed.
02
Drugs
hydroquinonearbutin
03
Conditions
Hyperpigmentation
Beyond the preview
Go deeper on TCTR20190614008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190614008.